Evidence map›Paper›PMID 31792256›Full record

Trial reportScientific reports2019

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients.

Aglaia Schiza, Sandra Irenaeus, Francisco Ortiz-Nieto, Angelica Loskog, Thomas Tötterman, Anders Sundin, Gustav J Ullenhag, Håkan Ahlström

Open access · goldAbstract readClinical Trial, Phase IClinical Trial, Phase IIComparative Study
In one paragraph

Trial report in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Imaging the hallmarks of cancer.Nature reviews. Cancer · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. MRI techniques for immunotherapy monitoring.Journal for immunotherapy of cancer · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Aglaia SchizaDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Dag Hammarskjoldsvag 20, 751 85, Uppsala, Sweden. aglaia.schiza@igp.uu.se.ORCID http://orcid.org/0000-0002-5514-3637
Sandra IrenaeusDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Dag Hammarskjoldsvag 20, 751 85, Uppsala, Sweden.
Francisco Ortiz-NietoDepartment of Surgical Sciences, Uppsala University, 751 85, Uppsala, Sweden.
Angelica LoskogDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Dag Hammarskjoldsvag 20, 751 85, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-8583-6138
Thomas TöttermanDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Dag Hammarskjoldsvag 20, 751 85, Uppsala, Sweden.
Anders SundinDepartment of Surgical Sciences, Uppsala University, 751 85, Uppsala, Sweden.
Gustav J UllenhagDepartment of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Dag Hammarskjoldsvag 20, 751 85, Uppsala, Sweden.
Håkan AhlströmDepartment of Surgical Sciences, Uppsala University, 751 85, Uppsala, Sweden.
Uppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose was to evaluate the potential of diffusion-weighted-magnetic resonance imaging (DW-MRI) and

Indexed as

Diffusion Magnetic Resonance ImagingPositron Emission Tomography Computed TomographyAdenoviridaeAdultAgedCD40 LigandFemaleFluorodeoxyglucose F18Follow-Up StudiesGenetic TherapyHumansImmunotherapyKaplan-Meier EstimateMaleMelanomaMiddle AgedCD40 LigandFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID31792256
PMCPMC6889008
OpenAlexW2989981102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.